Fifth Third Bancorp’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-618
Closed -$49K 2588
2021
Q1
$49K Buy
618
+370
+149% +$28.9K ﹤0.01% 1445
2020
Q4
$20K Buy
248
+124
+100% +$7.27K ﹤0.01% 1714
2020
Q3
$5K Sell
124
-4
-3% -$197 ﹤0.01% 1920
2020
Q2
$6K Sell
128
-506
-80% -$18.9K ﹤0.01% 1857
2020
Q1
$23K Sell
634
-131
-17% -$7.45K ﹤0.01% 1496
2019
Q4
$54K Buy
765
+58
+8% +$4.21K ﹤0.01% 1373
2019
Q3
$53K Sell
707
-42
-6% -$3.56K ﹤0.01% 1339
2019
Q2
$60K Sell
749
-2,879
-79% -$202K ﹤0.01% 1288
2019
Q1
$243K Buy
3,628
+628
+21% +$47.6K ﹤0.01% 818
2018
Q4
$223K Buy
3,000
+200
+7% +$16.5K ﹤0.01% 828
2018
Q3
$258K Buy
+2,800
New +$267K ﹤0.01% 827
2016
Q3
Sell
-70
Closed -$5K 2343
2016
Q2
$5K Buy
70
+40
+133% +$2.76K ﹤0.01% 1992
2016
Q1
$2K Sell
30
-70
-70% -$4.39K ﹤0.01% 2198
2015
Q4
$6K Buy
100
+2
+2% +$122 ﹤0.01% 2150
2015
Q3
$6K Buy
98
+34
+53% +$1.8K ﹤0.01% 2247
2015
Q2
$3K Buy
64
+1
+2% +$49 ﹤0.01% 2494
2015
Q1
$3K Buy
+63
New +$2.79K ﹤0.01% 2407

Fifth Third Bancorp's CMD Position: Q2 2021 in Review

Fifth Third Bancorp sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 618 shares — an estimated $49K sold.

Fifth Third Bancorp first reported a position in CMD in Q1 2015 and held it in 17 quarters. The position peaked at $258K in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Fifth Third Bancorp reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 618 Cantel Medical Corporation shares in Q2 2021, an estimated $49K.
  • Fifth Third Bancorp first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 17 quarters.
  • Fifth Third Bancorp's Cantel Medical Corporation position peaked at $258K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Fifth Third Bancorp's 13F filing for Q2 2021, filed 6 Aug 2021.